Weight loss guaranteed! But what impact on your diet? A review of GLP-1 and GIP/GLP-1 interventions

FHS
July 30, 2024
3:10 am

Researchers reviewed studies on dietary impacts of GLP-1 and GIP/GLP-1 receptor agonists in obesity and T2D patients, finding significant caloric reduction but limited evaluation of dietary composition.

Pharmaceutical Technology | Drug Development News & Views Updated DailyHome – Pharmaceutical Technology

Latest Issue Pharma Technology Focus Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read

September 27, 2024

Moderna posts reported net loss of $3.6bn in Q3 earnings – Pharmaceutical Technology

Moderna has six Phase III programmes underway, including one for a CMV vaccine, which has completed enrolment. Credit: Tada Images via www.shutterstock.com. Moderna has posted

November 2, 2023

Scientists uncover two Crohn’s disease subtypes using lab-grown intestines, offering hope for personalized therapies

Researchers used stem-cell derived organoids from Crohn’s disease patients to identify two molecular subtypes, paving the way for personalized treatments targeting specific disease characteristics.

October 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.